LDL particle size : an important drug target?

Saved in:

Bibliographic Details
Published in:	British journal of clinical pharmacology Vol. 48; no. 2; pp. 125 - 133
Main Authors:	RAJMAN, I, EACHO, P. I, CHOWIENCZYK, P. J, RITTER, J. M
Format:	Journal Article
Language:	English
Published:	London Blackwell Science 01-08-1999 Blackwell Science Inc
Subjects:	Arteriosclerosis - blood Arteriosclerosis - physiopathology Biological and medical sciences Cardiovascular Agents - pharmacology Disorders of blood lipids. Hyperlipoproteinemia General and cellular metabolism. Vitamins Humans Lipoproteins, LDL - chemistry Lipoproteins, LDL - physiology Medical sciences Metabolic diseases Particle Size Pharmacology. Drug treatments Reviews Human Pathogenesis Size Cardiovascular disease Metabolic diseases Lipids Hyperlipoproteinemia Review Coronary heart disease Density Vascular disease Lipoprotein LDL Chemotherapy Treatment Atherosclerosis Dyslipemia Antilipemic agent
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Author	EACHO, P. I RAJMAN, I CHOWIENCZYK, P. J RITTER, J. M
Author_xml	– sequence: 1 givenname: I surname: RAJMAN fullname: RAJMAN, I organization: Clinical Pharmacology, Eli Lilly and Company, Lilly Research Centre, Erl Wood Manor, Windlesham, United Kingdom – sequence: 2 givenname: P. I surname: EACHO fullname: EACHO, P. I organization: Cardiovascular Research Division Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States – sequence: 3 givenname: P. J surname: CHOWIENCZYK fullname: CHOWIENCZYK, P. J organization: Clinical Pharmacology, King's College London, St Thomas'Hospital, London, United Kingdom – sequence: 4 givenname: J. M surname: RITTER fullname: RITTER, J. M organization: Clinical Pharmacology, King's College London, St Thomas'Hospital, London, United Kingdom
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1899864$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/10417486$$D View this record in MEDLINE/PubMed
BookMark	eNpVkMtOwzAQRS0Eog_4BZQFYpfgcWLHZgFC5SlVYgNry43tkiov7AQVvp6EVqWsZjHn3hmdCTqs6sogFACOACfschVBzGhIgNAIhBARxkJAtD5A493iEI1xjFlICYURmni_whhiYPQYjfoSSBPOxiic382DRrk2zwoT-PzbBFeBqoK8bGrXqqoNtOuWQavc0rQ3J-jIqsKb0-2coreH-9fZUzh_eXye3c7DjAK0oSZ6sbA8EXbBudapEcSkxKZWYQHKUs0zS2KNE5uC0ZgzUJrGxlpLDU8TG0_R9aa36Ral0ZmpWqcK2bi8VO5L1iqX_zdV_i6X9ackGBLCWV9wsS1w9UdnfCvL3GemKFRl6s5L1utKYjaAfANmrvbeGbs7AlgOruVKDkrloFQOruWva7nuo2f7T-4FN3J74HwLKJ-pwjpVZbn_47gQnCXxDxwMipE
CODEN	BCPHBM
CitedBy_id	crossref_primary_10_1016_j_jcmgh_2020_09_007 crossref_primary_10_2217_nnm_2016_0336 crossref_primary_10_1046_j_1365_2265_2002_01638_x crossref_primary_10_1016_S0733_8651_02_00089_9 crossref_primary_10_1517_13543784_8_11_1763 crossref_primary_10_1161_01_STR_0000014924_29238_E1 crossref_primary_10_1161_01_STR_0000015782_92427_B6 crossref_primary_10_1515_tjb_2021_0298 crossref_primary_10_1007_s11538_019_00646_5 crossref_primary_10_1038_ncomms6479 crossref_primary_10_1016_j_jacl_2017_06_012 crossref_primary_10_1016_j_ijpharm_2019_04_062 crossref_primary_10_3892_ijmm_2020_4542 crossref_primary_10_1016_j_cca_2021_06_012 crossref_primary_10_3390_md19090495 crossref_primary_10_1016_S0002_9149_02_02636_X crossref_primary_10_1371_journal_pone_0123088 crossref_primary_10_1002_clc_4960281109 crossref_primary_10_1186_s12906_022_03539_8 crossref_primary_10_5551_jat_12_237 crossref_primary_10_1038_s41598_020_74236_0 crossref_primary_10_1161_01_HYP_0000056997_40992_41 crossref_primary_10_1016_j_clnu_2019_02_008 crossref_primary_10_1186_s12933_020_01189_z crossref_primary_10_1186_s12944_017_0579_2 crossref_primary_10_1016_j_jsps_2013_12_015 crossref_primary_10_1016_j_pmedr_2015_12_012 crossref_primary_10_1007_s13410_017_0559_0 crossref_primary_10_1186_1476_511X_13_112 crossref_primary_10_3390_antiox13050583 crossref_primary_10_1016_j_atherosclerosis_2015_06_012 crossref_primary_10_1021_acsnano_6b08089 crossref_primary_10_1161_JAHA_116_005162 crossref_primary_10_1007_s11538_017_0367_1 crossref_primary_10_1038_s41467_019_11259_w crossref_primary_10_3390_ijms21176373 crossref_primary_10_1371_journal_pntd_0003904 crossref_primary_10_1016_j_plefa_2014_05_002 crossref_primary_10_1371_journal_pone_0090497
Cites_doi	10.1038/327237a0 10.1093/clinchem/19.2.228 10.1016/S0022-2275(20)39928-4 10.1097/00041433-199412000-00002 10.1097/00041433-199508000-00003 10.1161/01.ATV.14.10.1569 10.1016/0167-4838(90)90100-T 10.1016/S0021-9150(97)88234-2 10.1093/oxfordjournals.qjmed.a068888 10.1016/S0022-2275(20)35367-0 10.1016/S0021-9258(17)42379-9 10.1016/0021-9150(96)05881-9 10.1016/S0021-9258(19)62020-X 10.1161/01.CIR.95.1.69 10.1097/00041433-199410000-00005 10.1093/clinchem/23.10.1826 10.1172/JCI103182 10.1056/NEJM199411033311803 10.1016/S0022-2275(20)38178-5 10.1161/01.ATV.11.2.298 10.1001/jama.1996.03530260042029 10.1073/pnas.94.9.4318 10.1073/pnas.89.2.708 10.1161/01.ATV.12.11.1284 10.1097/00041433-199410000-00002 10.1056/NEJM198904063201407 10.1111/j.1365-2796.1991.tb00370.x 10.1016/0026-0495(83)90194-4 10.1016/0021-9150(94)90129-5 10.1097/00041433-199408000-00002 10.1006/bbrc.1993.1550 10.1074/jbc.270.22.12953 10.1097/00019501-199304000-00010 10.1056/NEJM199610033351401 10.1097/00041433-199405030-00007 10.1016/S0022-2275(20)41629-3 10.1016/0021-9150(96)05811-X 10.1016/0021-9150(92)90173-E 10.1007/s001250050658 10.1016/0021-9150(90)90131-2 10.1161/01.ATV.7.5.483 10.1172/JCI116541 10.1016/S0022-2275(20)42342-9 10.1016/S0021-9150(97)00315-8 10.1161/01.RES.77.3.510 10.1016/S0140-6736(98)22003-4 10.1016/S0002-9149(98)00039-3 10.1161/01.ATV.16.6.763 10.1016/S0002-9149(99)80474-3 10.1016/S0002-9149(99)80552-9 10.1016/S0022-2275(20)32551-7 10.1001/jama.260.13.1917 10.1111/j.1365-2362.1992.tb01478.x 10.2337/diabetes.47.12.1841 10.1016/0005-2760(95)00172-7 10.2337/diacare.21.5.796 10.1016/S0022-2275(20)42003-6 10.1056/NEJM199610313351804 10.1016/0021-9150(94)90062-0 10.1016/S0022-2275(20)40756-4 10.1161/01.ATV.17.11.2507 10.1161/01.ATV.13.5.702 10.1016/0005-2760(93)90294-J 10.2337/diab.46.3.433 10.1056/NEJM199511163332001 10.1016/0006-2952(95)02072-1 10.1016/S0140-6736(96)91343-4 10.1016/0026-0495(95)90134-5 10.1007/BF00192552 10.1016/0021-9150(92)90177-I 10.3109/07853899109148041 10.1161/01.ATV.14.5.653 10.1016/S0022-2275(20)38518-7 10.1038/320454a0 10.1073/pnas.72.6.2347 10.1016/0021-9150(93)90071-2
ContentType	Journal Article
Copyright	1999 INIST-CNRS 1999 Blackwell Science Ltd 1999
Copyright_xml	– notice: 1999 INIST-CNRS – notice: 1999 Blackwell Science Ltd 1999
DBID	IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM
DOI	10.1046/j.1365-2125.1999.00991.x
DatabaseName	Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic
Database_xml	– sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Pharmacy, Therapeutics, & Pharmacology
EISSN	1365-2125
EndPage	133
ExternalDocumentID	10_1046_j_1365_2125_1999_00991_x 10417486 1899864
Genre	Journal Article Review
GroupedDBID	--- .3N .55 .GA .GJ .Y3 05W 08R 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJUZ AANLZ AAONW AAPBV AASGY AAUGY AAVGM AAXRX AAZKR ABCQN ABCUV ABCVL ABEML ABHUG ABOCM ABPTK ABPVW ABWRO ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFGKR AFPWT AFVGU AFZJQ AGJLS AIACR AIAGR AIURR AIWBW AJBDE AKALU ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HF~ HYE HZI HZ~ IHE IPNFZ IQODW IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT ABQWH AFFPM AHBTC AITYG CGR CUY CVF ECM EIF HGLYW NPM OIG AAMNL AAYXX CITATION 7X8 5PM
ID	FETCH-LOGICAL-c511t-d2dbbf849fb88dd7e92e72f7fa091af5d8cf23d04f71ed0861ad53efff5e874f3
ISSN	0306-5251
IngestDate	Tue Sep 17 20:53:42 EDT 2024 Sat Aug 17 00:32:52 EDT 2024 Thu Nov 21 21:54:20 EST 2024 Sat Sep 28 08:34:16 EDT 2024 Sun Oct 29 17:07:24 EDT 2023
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	Human Pathogenesis Size Cardiovascular disease Metabolic diseases Lipids Hyperlipoproteinemia Review Coronary heart disease Density Vascular disease Lipoprotein LDL Chemotherapy Treatment Atherosclerosis Dyslipemia Antilipemic agent
Language	English
License	CC BY 4.0
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c511t-d2dbbf849fb88dd7e92e72f7fa091af5d8cf23d04f71ed0861ad53efff5e874f3
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
OpenAccessLink	https://europepmc.org/articles/pmc2014286?pdf=render
PMID	10417486
PQID	69914366
PQPubID	23479
PageCount	9
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_2014286 proquest_miscellaneous_69914366 crossref_primary_10_1046_j_1365_2125_1999_00991_x pubmed_primary_10417486 pascalfrancis_primary_1899864
PublicationCentury	1900
PublicationDate	1999-08-01
PublicationDateYYYYMMDD	1999-08-01
PublicationDate_xml	– month: 08 year: 1999 text: 1999-08-01 day: 01
PublicationDecade	1990
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	British journal of clinical pharmacology
PublicationTitleAlternate	Br J Clin Pharmacol
PublicationYear	1999
Publisher	Blackwell Science Blackwell Science Inc
Publisher_xml	– name: Blackwell Science – name: Blackwell Science Inc
References	e_1_2_9_52_2 e_1_2_9_73_2 e_1_2_9_71_2 e_1_2_9_10_2 e_1_2_9_33_2 e_1_2_9_77_2 e_1_2_9_31_2 e_1_2_9_75_2 Chapman MJ (e_1_2_9_12_2) 1988; 29 Lehmann JM (e_1_2_9_81_2) 1995; 270 Van Antwerpen R (e_1_2_9_11_2) 1994; 35 Dyce MC (e_1_2_9_51_2) 1993; 88 Schoonjans K (e_1_2_9_83_2) 1996; 37 e_1_2_9_14_2 e_1_2_9_37_2 e_1_2_9_16_2 e_1_2_9_35_2 e_1_2_9_58_2 e_1_2_9_18_2 e_1_2_9_79_2 e_1_2_9_39_2 Chen GC (e_1_2_9_48_2) 1994; 269 Dejager S (e_1_2_9_42_2) 1993; 34 e_1_2_9_41_2 Naito H (e_1_2_9_57_2) 1995; 38 e_1_2_9_60_2 Ghazzi MN (e_1_2_9_80_2) 1997; 46 e_1_2_9_20_2 e_1_2_9_45_2 Krauss RM (e_1_2_9_54_2) 1982; 23 e_1_2_9_66_2 e_1_2_9_22_2 e_1_2_9_43_2 e_1_2_9_64_2 e_1_2_9_85_2 e_1_2_9_6_2 e_1_2_9_4_2 Shen MMS (e_1_2_9_15_2) 1981; 22 e_1_2_9_2_2 Nigon E (e_1_2_9_46_2) 1991; 32 Naito HK (e_1_2_9_55_2) 1973; 19 e_1_2_9_8_2 Galeano NF (e_1_2_9_47_2) 1994; 269 e_1_2_9_24_2 e_1_2_9_49_2 e_1_2_9_26_2 e_1_2_9_68_2 e_1_2_9_28_2 e_1_2_9_74_2 e_1_2_9_30_2 e_1_2_9_72_2 e_1_2_9_78_2 e_1_2_9_34_2 e_1_2_9_76_2 e_1_2_9_32_2 e_1_2_9_53_2 e_1_2_9_70_2 Muniz N (e_1_2_9_56_2) 1977; 10 Scandinavian Simvastatin Survival Study Group (e_1_2_9_3_2) 1995; 344 e_1_2_9_13_2 e_1_2_9_38_2 e_1_2_9_59_2 e_1_2_9_36_2 e_1_2_9_19_2 e_1_2_9_40_2 e_1_2_9_63_2 Galeano NF (e_1_2_9_50_2) 1998; 39 e_1_2_9_61_2 La Belle M (e_1_2_9_21_2) 1990; 31 e_1_2_9_44_2 e_1_2_9_67_2 e_1_2_9_82_2 e_1_2_9_23_2 e_1_2_9_65_2 e_1_2_9_84_2 e_1_2_9_7_2 e_1_2_9_5_2 Musliner TA (e_1_2_9_17_2) 1988; 34 e_1_2_9_9_2 Bakker‐Arkema RG (e_1_2_9_62_2) 1996; 275 e_1_2_9_25_2 e_1_2_9_27_2 e_1_2_9_69_2 e_1_2_9_29_2
References_xml	– ident: e_1_2_9_37_2 doi: 10.1038/327237a0 – volume: 19 start-page: 228 year: 1973 ident: e_1_2_9_55_2 article-title: Polyacrylamide gel disc electrophoresis as a screening procedure for serum lipoprotein abnormalities. publication-title: Clin Chem doi: 10.1093/clinchem/19.2.228 contributor: fullname: Naito HK – volume: 35 start-page: 2223 year: 1994 ident: e_1_2_9_11_2 article-title: Cryo‐electron microscopy reveals low density lipoprotein substructure. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)39928-4 contributor: fullname: Van Antwerpen R – ident: e_1_2_9_24_2 – ident: e_1_2_9_30_2 doi: 10.1097/00041433-199412000-00002 – ident: e_1_2_9_45_2 doi: 10.1097/00041433-199508000-00003 – ident: e_1_2_9_60_2 doi: 10.1161/01.ATV.14.10.1569 – ident: e_1_2_9_16_2 doi: 10.1016/0167-4838(90)90100-T – ident: e_1_2_9_63_2 doi: 10.1016/S0021-9150(97)88234-2 – ident: e_1_2_9_25_2 doi: 10.1093/oxfordjournals.qjmed.a068888 – volume: 22 start-page: 236 year: 1981 ident: e_1_2_9_15_2 article-title: Heterogeneity of serum low density lipoproteins in normal human subjects. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)35367-0 contributor: fullname: Shen MMS – volume: 269 start-page: 511 year: 1994 ident: e_1_2_9_47_2 article-title: Apoprotein B structure and receptor recognition of triglyceride rich low density lipoprotein is modified in small LDL but not in triglyceride rich LDL of normal size. publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)42379-9 contributor: fullname: Galeano NF – ident: e_1_2_9_32_2 doi: 10.1016/0021-9150(96)05881-9 – volume: 269 start-page: 29 121 year: 1994 ident: e_1_2_9_48_2 article-title: Conformational differences in human apolipoprotein B‐100 among subspecies of LDL. Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from subjects. publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)62020-X contributor: fullname: Chen GC – ident: e_1_2_9_33_2 doi: 10.1161/01.CIR.95.1.69 – ident: e_1_2_9_13_2 doi: 10.1097/00041433-199410000-00005 – ident: e_1_2_9_29_2 – volume: 88 start-page: I 466 year: 1993 ident: e_1_2_9_51_2 article-title: Indices of LDL particle size closely relate to endothelial dysfunction. publication-title: Circulation contributor: fullname: Dyce MC – volume: 10 start-page: 1826 year: 1977 ident: e_1_2_9_56_2 article-title: Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. publication-title: Clin Chem doi: 10.1093/clinchem/23.10.1826 contributor: fullname: Muniz N – ident: e_1_2_9_7_2 doi: 10.1172/JCI103182 – ident: e_1_2_9_75_2 doi: 10.1056/NEJM199411033311803 – volume: 23 start-page: 97 year: 1982 ident: e_1_2_9_54_2 article-title: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)38178-5 contributor: fullname: Krauss RM – ident: e_1_2_9_43_2 doi: 10.1161/01.ATV.11.2.298 – volume: 275 start-page: 128 year: 1996 ident: e_1_2_9_62_2 article-title: Efficacy and safety of a new HMG CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. publication-title: JAMA doi: 10.1001/jama.1996.03530260042029 contributor: fullname: Bakker‐Arkema RG – ident: e_1_2_9_84_2 doi: 10.1073/pnas.94.9.4318 – ident: e_1_2_9_28_2 doi: 10.1073/pnas.89.2.708 – ident: e_1_2_9_26_2 doi: 10.1161/01.ATV.12.11.1284 – ident: e_1_2_9_2_2 doi: 10.1097/00041433-199410000-00002 – ident: e_1_2_9_41_2 doi: 10.1056/NEJM198904063201407 – ident: e_1_2_9_61_2 doi: 10.1111/j.1365-2796.1991.tb00370.x – volume: 34 start-page: B78 year: 1988 ident: e_1_2_9_17_2 article-title: Lipoprotein subspecies and risk of coronary disease. publication-title: Clin Chem contributor: fullname: Musliner TA – ident: e_1_2_9_10_2 doi: 10.1016/0026-0495(83)90194-4 – ident: e_1_2_9_31_2 doi: 10.1016/0021-9150(94)90129-5 – ident: e_1_2_9_40_2 doi: 10.1097/00041433-199408000-00002 – ident: e_1_2_9_52_2 doi: 10.1006/bbrc.1993.1550 – volume: 270 start-page: 12 953 year: 1995 ident: e_1_2_9_81_2 article-title: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator receptor g (PPARg). publication-title: J Biol Chem doi: 10.1074/jbc.270.22.12953 contributor: fullname: Lehmann JM – ident: e_1_2_9_22_2 doi: 10.1097/00019501-199304000-00010 – volume: 38 start-page: 615 year: 1995 ident: e_1_2_9_57_2 article-title: LDL particle size decreases in non‐insulin dependant diabetic patients with nephropathy. publication-title: J Japan Diab Soc contributor: fullname: Naito H – ident: e_1_2_9_5_2 doi: 10.1056/NEJM199610033351401 – ident: e_1_2_9_27_2 doi: 10.1097/00041433-199405030-00007 – volume: 32 start-page: 1741 year: 1991 ident: e_1_2_9_46_2 article-title: Discrete subspecies of human LDL are heterogeneous in their interactions with the cellular LDL receptor. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)41629-3 contributor: fullname: Nigon E – ident: e_1_2_9_79_2 doi: 10.1016/0021-9150(96)05811-X – ident: e_1_2_9_67_2 doi: 10.1016/0021-9150(92)90173-E – ident: e_1_2_9_78_2 doi: 10.1007/s001250050658 – ident: e_1_2_9_53_2 doi: 10.1016/0021-9150(90)90131-2 – ident: e_1_2_9_8_2 doi: 10.1161/01.ATV.7.5.483 – ident: e_1_2_9_34_2 doi: 10.1172/JCI116541 – volume: 31 start-page: 1577 year: 1990 ident: e_1_2_9_21_2 article-title: Differences in carbohydrate content of LDL lipoproteins associated with LDL subclass patterns. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)42342-9 contributor: fullname: La Belle M – ident: e_1_2_9_82_2 doi: 10.1016/S0021-9150(97)00315-8 – ident: e_1_2_9_36_2 doi: 10.1161/01.RES.77.3.510 – ident: e_1_2_9_76_2 doi: 10.1016/S0140-6736(98)22003-4 – ident: e_1_2_9_65_2 doi: 10.1016/S0002-9149(98)00039-3 – ident: e_1_2_9_71_2 doi: 10.1161/01.ATV.16.6.763 – ident: e_1_2_9_6_2 doi: 10.1016/S0002-9149(99)80474-3 – ident: e_1_2_9_58_2 doi: 10.1016/S0002-9149(99)80552-9 – ident: e_1_2_9_70_2 doi: 10.1016/0021-9150(92)90173-E – volume: 39 start-page: 1263 year: 1998 ident: e_1_2_9_50_2 article-title: Small dense low density lipoprotein has increased affinity for LDL receptor‐independent cell surface binding sites: a potential mechanism for increased atherogenicity, publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)32551-7 contributor: fullname: Galeano NF – ident: e_1_2_9_18_2 doi: 10.1001/jama.260.13.1917 – ident: e_1_2_9_64_2 doi: 10.1111/j.1365-2362.1992.tb01478.x – ident: e_1_2_9_85_2 doi: 10.2337/diabetes.47.12.1841 – volume: 344 start-page: 1383 year: 1995 ident: e_1_2_9_3_2 article-title: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). publication-title: Lancet contributor: fullname: Scandinavian Simvastatin Survival Study Group – ident: e_1_2_9_23_2 doi: 10.1016/0005-2760(95)00172-7 – ident: e_1_2_9_77_2 doi: 10.2337/diacare.21.5.796 – volume: 37 start-page: 907 year: 1996 ident: e_1_2_9_83_2 article-title: Role of peroxisome proliferator‐activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)42003-6 contributor: fullname: Schoonjans K – ident: e_1_2_9_74_2 doi: 10.1056/NEJM199610313351804 – ident: e_1_2_9_69_2 doi: 10.1016/0021-9150(94)90062-0 – volume: 34 start-page: 295 year: 1993 ident: e_1_2_9_42_2 article-title: Dense LDL subspecies with diminished oxidative resistance predominate in combined hyperlipidaemia. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)40756-4 contributor: fullname: Dejager S – ident: e_1_2_9_49_2 doi: 10.1161/01.ATV.17.11.2507 – ident: e_1_2_9_19_2 doi: 10.1161/01.ATV.13.5.702 – ident: e_1_2_9_20_2 doi: 10.1016/0005-2760(93)90294-J – volume: 46 start-page: 433 year: 1997 ident: e_1_2_9_80_2 article-title: Cardiac and glycemic benefits of troglitazone treatment in NIDDM. publication-title: Diabetes doi: 10.2337/diab.46.3.433 contributor: fullname: Ghazzi MN – ident: e_1_2_9_4_2 doi: 10.1056/NEJM199511163332001 – ident: e_1_2_9_44_2 doi: 10.1016/0006-2952(95)02072-1 – ident: e_1_2_9_14_2 doi: 10.1097/00041433-199412000-00002 – ident: e_1_2_9_72_2 doi: 10.1016/S0140-6736(96)91343-4 – ident: e_1_2_9_35_2 doi: 10.1016/0026-0495(95)90134-5 – ident: e_1_2_9_59_2 doi: 10.1007/BF00192552 – ident: e_1_2_9_66_2 doi: 10.1016/0021-9150(92)90177-I – ident: e_1_2_9_73_2 doi: 10.3109/07853899109148041 – ident: e_1_2_9_38_2 doi: 10.1161/01.ATV.14.5.653 – volume: 29 start-page: 442 year: 1988 ident: e_1_2_9_12_2 article-title: . Further resolution of the low‐density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)38518-7 contributor: fullname: Chapman MJ – ident: e_1_2_9_39_2 doi: 10.1038/320454a0 – ident: e_1_2_9_9_2 doi: 10.1073/pnas.72.6.2347 – ident: e_1_2_9_68_2 doi: 10.1016/0021-9150(93)90071-2
SSID	ssj0013165
Score	1.737176
SecondaryResourceType	review_article
SourceID	pubmedcentral proquest crossref pubmed pascalfrancis
SourceType	Open Access Repository Aggregation Database Index Database
StartPage	125
SubjectTerms	Arteriosclerosis - blood Arteriosclerosis - physiopathology Biological and medical sciences Cardiovascular Agents - pharmacology Disorders of blood lipids. Hyperlipoproteinemia General and cellular metabolism. Vitamins Humans Lipoproteins, LDL - chemistry Lipoproteins, LDL - physiology Medical sciences Metabolic diseases Particle Size Pharmacology. Drug treatments Reviews
Title	LDL particle size : an important drug target?
URI	https://www.ncbi.nlm.nih.gov/pubmed/10417486 https://search.proquest.com/docview/69914366 https://pubmed.ncbi.nlm.nih.gov/PMC2014286
Volume	48
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe68YKEJr4pMPAD2ksbqU4cx-UFoTXTgGpMI5P2Zjm1zQpaWi2tYPvrOSeOk45JwAMvUWTXcXV3udyd736H0BtwkYmMgQM8NDKgzJCAk4gFNAb7Ph-zGYltNfLhl-TojE9SmvZ6TTugduy_chrGgNe2cvYfuO0fCgNwDzyHK3Adrn_F9-lkOli68UE5v65qz-Elnl9UlnaxGqjL9ddBnQF-I62vQTjqwEn4yslli3Hto_An8psLoPrYa2q7r1SmaTu2f774YTXI9dX3esbHpk_mK9cY5KMLyypXkTf26W--8GrEwJ91uLFOqVLeEZ6woyFJXefsPrakRsH4TY-PKgDjJgkP1tiqSossCuZsk9_Zhc4--iwOTqdTkaVn2Ra6E4LWsY0UJh8-tUdKpOor6v-tS-tyR9y37rNhq9xbyhLIbep-J7c5JDfzajuGSnYf7TgPA7-vReAB6uniIdo7rtl3NcRZW3FXDvEePu4w9hEagvzgRn6wlZ-3WBbYSw-20oNr6Xn3GJ0epNn-YeA6agQzMKxXgQpVnhtOxybnXKlEj0OdhCYxEsxGaWLFZyaM1IiahGgF3i6RKo60MSbWPKEmeoK2i0WhnyGcq3ykKJOa5glV8AQ6i3lE5FhZBLyc9xFpaCeWNXCKqBIeqC0OtPQWlt7C0ltU9BY_-2h3g8jtQhsVYLSPXjdEF6AF7dGWLPRiXQoG62nEWB89rVnQ2ZOC081hJtlgjv-BxVffnCnm5xXOOtjG4Jyz53_c9QW6274YL9H26nKtd9FWqdavKhn8BWzRkko
link.rule.ids	230,315,782,786,887,27934,27935
linkProvider	Flying Publisher
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LDL+particle+size%3A+an+important+drug+target%3F&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=Rajman%2C+I&rft.au=Eacho%2C+P+I&rft.au=Chowienczyk%2C+P+J&rft.au=Ritter%2C+J+M&rft.date=1999-08-01&rft.issn=0306-5251&rft.volume=48&rft.issue=2&rft.spage=125&rft.epage=133&rft_id=info:doi/10.1046%2Fj.1365-2125.1999.00991.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon